MARKET COMPOSITE
Market TodayThemes and Stocks SummaryThematic Stock SearchDaily Refresh Schedule
ISR - Isoray, Inc.
$1.36
0.13(10.57%)9:00:00 PM 2/24/2021
Isoray Inc. is a national isotope-based medical company and the sole producer of Cesium brachytherapy sources, which are expanding brachytherapy treatments for difficult to treat cancers. Isoray is a registered manufacturer with the FDA and holds multiple 510 clearances for brachytherapy devices. The brachytherapy isotopes are sold under the brandname Blu. The company went public in 2005. Isoray’s corporate headquarters is located at 350 Hills Street, Suite 106, Richland WA 99354.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

No summary
Related Topics
Peers

Stock news

    02/21/2021ISR
    Here's Why We're Not At All Concerned With Isoray's (NYSEMKT:ISR) Cash Burn Situation

    Just because a business does not make any money, does not mean that the stock will go down. For example, although...

    02/17/2021ISR
    ROCE Insights For IsoRay

    During Q2, IsoRay's (AMEX:ISR) reported sales totaled $2.36 million. Despite a 21.29% in earnings, the company posted a loss of $866.00 thousand. In Q1, IsoRay brought in $2.38 million in sales but lost $714.00 thousand in earnings. What Is Return On Capital Employed? Changes in earnings and sales indicate shifts in IsoRay's Return on Capital Employed, a measure of yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company a...

    02/16/2021ISR
    Isoray Announces the Appointment of Lisa Lauer As Vice President Business Development

    RICHLAND, Wash., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE American: ISR), a medical technology company and seed brachytherapy innovator, today announced that Lisa Lauer has been appointed Vice President, Business Development. CEO Lori Woods says Lauer’s appointment marks another important step forward for the Company, “Lisa Lauer brings deep industry experience and market knowledge to the Company. Lisa's particular expertise in technologies used alone or in combination with immunothe...

    02/9/2021ISR
    IsoRay (ISR) Reports Q2 Loss, Lags Revenue Estimates

    IsoRay (ISR) delivered earnings and revenue surprises of 0.00% and -0.04%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

    02/9/2021ISR
    Isoray Announces Second Quarter Fiscal 2021 Financial Results

    Revenue Increased 7% Year-Over-YearNon-Prostate Brachytherapy Revenue Increased 92% Year-Over-Year RICHLAND, Wash., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced its financial results for the second quarter fiscal 2021 ended December 31, 2020. Revenue for the second quarter of fiscal 2021 grew 7% to $2.36 million versus $2.21 million in...

    02/9/2021ISR
    IsoRay, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / February 9, 2021 / IsoRay, Inc. (ASE:ISR) will be discussing their earnings results in their 2021 Second Quarter Earnings call to be held on February 9, 2021 at 4:30 PM Eastern Time.

    02/5/2021ISR
    Isoray To Announce Second Quarter Fiscal 2021 Financial Results on February 9, 2021

    Conference Call is Tuesday, February 9, 2021 at 4:30 p.m. ET/1:30 p.m. PT RICHLAND, Wash., Feb. 05, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced that it will host a conference call to discuss its financial results for the second quarter fiscal year 2021 ended December 31, 2020 on Tuesday, February 9, 2021, at 4:30 p.m. Eastern Time. The Company...